Trading Signals: GSK Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Oct. 27, 2023)(GlaxoSmithKline plc )
| GSK latest price $51.9600 (-0.15%) ($51.5300 - $52.1900) on Thu. Jan. 30, 2014. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 0.9% (three month average) | | RSI | 47 | | Latest Price | $51.9600(-0.15%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | GSK declines -1.1% a day on average for past five trading days. | | Weekly Trend | GSK declines -0.1% a week on average for past two weeks. | | Market Behavior | Normal for large cap. Normal for small cap. | | Correlated ETFs | Broad market will support GSK advance at 0% a week (0% probability)
EWG(46%) SPY(46%) XLP(45%) EWP(44%) EWI(42%) | | Factors Impacting GSK price | GSK will decline at least -0.45% in a week (0% probabilities).
UUP(-14%) TLT(-14%) TIP(-2%) IGOV(-2%) DIA(-2%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -0.45% (StdDev 0.9%) | | Hourly BBV | 0 () | | Intraday Trend | 0.5% | | | | | |
|
| Resistance Level | $53.2 | | 5 Day Moving Average | $52.74(-1.48%) | | 10 Day Moving Average | $53.56(-2.99%) | | 20 Day Moving Average | $53.2(-2.33%) | | To recent high | -5.4% | | To recent low | 1.8% | | Market Cap | $129.302b | | | | | | |
GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals, Vaccines, Consumer Healthcare, and Corporate Executive Team (CET). The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The CET segment refers to the management of business activities. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom. |